loadpatents
Patent applications and USPTO patent grants for Rauchenberger; Robert.The latest application filed is for "medical device for administering anti-il-23 antibodies".
Patent | Date |
---|---|
Anti-IGF antibodies Grant 11,299,538 - Adam , et al. April 12, 2 | 2022-04-12 |
Medical Device for Administering Anti-IL-23 Antibodies App 20210188966 - Benson; Jacqueline ;   et al. | 2021-06-24 |
Methods of treatment using human anti-IL-23 antibodies Grant 10,954,297 - Benson , et al. March 23, 2 | 2021-03-23 |
Anti-igf Antibodies App 20190225681 - ADAM; Paul ;   et al. | 2019-07-25 |
Anti-IGF antibodies Grant 10,179,810 - Adam , et al. Ja | 2019-01-15 |
Methods of Treatment Using Human Anti-IL-23 Antibodies App 20180291096 - Benson; Jacqueline ;   et al. | 2018-10-11 |
Antibodies targeting M-CSF Grant 10,081,675 - Dodeller , et al. September 25, 2 | 2018-09-25 |
Human anti-IL-23 antibodies, compositions, methods and uses Grant 10,030,070 - Benson , et al. July 24, 2 | 2018-07-24 |
Toll-like Receptor 3 Antagonists App 20180179294 - Cunningham; Mark ;   et al. | 2018-06-28 |
Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist Grant 9,932,404 - Cunningham , et al. April 3, 2 | 2018-04-03 |
Antibodies Targeting M-csf App 20180057581 - Dodeller; Francis ;   et al. | 2018-03-01 |
Antibodies targeting M-CSF Grant 9,856,316 - Dodeller , et al. January 2, 2 | 2018-01-02 |
Human Anti-IL-23 Antibodies, Compositions, Methods and Uses App 20170362316 - Benson; Jacqueline ;   et al. | 2017-12-21 |
Human anti-IL-23 antibodies, compositions, methods and uses Grant 9,783,607 - Benson , et al. October 10, 2 | 2017-10-10 |
Toll-Like Receptor 3 Antagonists App 20170058041 - Cunningham; Mark ;   et al. | 2017-03-02 |
Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists Grant 9,522,957 - Cunningham , et al. December 20, 2 | 2016-12-20 |
Toll-like receptor 3 antagonists Grant 9,481,731 - Cunningham , et al. November 1, 2 | 2016-11-01 |
Platelet-derived growth factor B specific antibodies and compositions and uses thereof Grant 9,428,577 - Arch , et al. August 30, 2 | 2016-08-30 |
Human Anti-IL-23 Antibodies, Compositions, Methods and Uses App 20160237151 - Benson; Jacqueline ;   et al. | 2016-08-18 |
Human anti-IL-23 antibodies, compositions, methods and uses Grant 9,353,181 - Benson , et al. May 31, 2 | 2016-05-31 |
Antibodies Targeting M-CSF App 20160102142 - Dodeller; Francis ;   et al. | 2016-04-14 |
Polynucleotides encoding Toll-Like Receptor 3 antagonists Grant 9,255,153 - Cunningham , et al. February 9, 2 | 2016-02-09 |
Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies Grant 9,238,693 - Cunningham , et al. January 19, 2 | 2016-01-19 |
Toll-Like Receptor 3 Antagonists App 20140212426 - Cunningham; Mark ;   et al. | 2014-07-31 |
Platelet-derived Growth Factor B Specific Antibodies And Compositions And Uses Thereof App 20140134176 - ARCH; Robert ;   et al. | 2014-05-15 |
Toll-Like 3 Receptor Antagonists App 20140093508 - Cunningham; Mark ;   et al. | 2014-04-03 |
Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20140017250 - Cunningham; Mark ;   et al. | 2014-01-16 |
Toll-Like Receptor 3 Antagonists App 20130280263 - Cunningham; Mark ;   et al. | 2013-10-24 |
Toll-like receptor 3 antagonists Grant 8,540,986 - Cunningham , et al. September 24, 2 | 2013-09-24 |
Toll-Like Receptor 3 Antagonists App 20130244281 - Cunningham; Mark ;   et al. | 2013-09-19 |
IL-17A antibodies Grant 8,519,107 - Almagro , et al. August 27, 2 | 2013-08-27 |
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases Grant 8,460,659 - Cunningham , et al. June 11, 2 | 2013-06-11 |
Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases App 20130090457 - Cunningham; Mark ;   et al. | 2013-04-11 |
Toll-like receptor 3 antagonists Grant 8,409,567 - Cunningham , et al. April 2, 2 | 2013-04-02 |
Human Anti-IL-23 Antibodies, Compositions, Methods and Uses App 20120251454 - Benson; Jacqueline ;   et al. | 2012-10-04 |
Methods of treatment using human anti-IL-23 antibodies Grant 8,221,760 - Benson , et al. July 17, 2 | 2012-07-17 |
Toll-like Receptor 3 Antagonists For The Treatment Of Metabolic And Cardiovascular Diseases App 20120064095 - Cunningham; Mark ;   et al. | 2012-03-15 |
Nucleic acids encoding human anti-IL-23 antibodies Grant 8,106,177 - Benson , et al. January 31, 2 | 2012-01-31 |
Methods of Treatment Using Human Anti-IL-23 Antibodies App 20110287028 - Benson; Jacqueline ;   et al. | 2011-11-24 |
IL-17A Antagonists App 20110236390 - Almagro; Juan Carlos ;   et al. | 2011-09-29 |
Nucleic Acids Encoding Human Anti-IL-23 Antibodies App 20110195455 - Benson; Jacqueline ;   et al. | 2011-08-11 |
Human anti-IL-23 antibodies, compositions, methods and uses Grant 7,993,645 - Benson , et al. August 9, 2 | 2011-08-09 |
Human anti-IL-23 antibodies, compositions, methods and uses Grant 7,935,344 - Benson , et al. May 3, 2 | 2011-05-03 |
Human Anti-IL-23 Antibodies, Compositions, Methods and Uses App 20110040249 - BENSON; JACQUELINE ;   et al. | 2011-02-17 |
Toll-Like Receptor 3 Antagonists App 20110008352 - Cunningham; Mark ;   et al. | 2011-01-13 |
Toll-Like Receptor 3 Antagonists App 20100166778 - Cunningham; Mark ;   et al. | 2010-07-01 |
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells App 20090325290 - Nagy; Zoltan ;   et al. | 2009-12-31 |
Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells Grant 7,521,047 - Nagy , et al. April 21, 2 | 2009-04-21 |
Anti-IL-13 antibodies, compositions, methods and uses App 20080044420 - Heavner; George A. ;   et al. | 2008-02-21 |
Human Anti-il-23 Antibodies, Compositions, Methods And Uses App 20070218064 - Benson; Jacqueline ;   et al. | 2007-09-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.